Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.37
+0.36 (2.12%)
Jun 3, 2026, 1:17 PM EDT - Market open
Crescent Biopharma Employees
Crescent Biopharma had 55 employees as of March 31, 2026. The number of employees increased by 11 or 25.00% since the number was last reported on December 31, 2025.
Employees
55
Change
11
Growth
25.00%
Revenue / Employee
$216,055
Profits / Employee
-$2,946,855
Market Cap
577.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 55 | 11 | 25.00% |
| Dec 31, 2025 | 44 | 38 | 633.33% |
| Dec 31, 2024 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| Solid Biosciences | 121 |
| BridgeBio Oncology Therapeutics | 92 |
| Aclaris Therapeutics | 73 |
| Alto Neuroscience | 68 |
| Zevra Therapeutics | 61 |
CBIO News
- 21 hours ago - Crescent Biopharma to Present at June Investor Conferences - GlobeNewsWire
- 1 day ago - Crescent Biopharma Transcript: AGM 2026 - Transcripts
- 2 days ago - Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 8 days ago - Crescent Biopharma Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 12 days ago - Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - GlobeNewsWire
- 13 days ago - Crescent Biopharma Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 20 days ago - Crescent Biopharma Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts